To address this question, primary healthy donor bone marrow-derived mesenchymal stromal cells (MSCs) were either cultured alone, treated with recombinant GRN, or co-cultured with primary patient-derived CLL cells (experimental setup is illustrated by Figure 3a). The gene discussed is GRN; the disease is B-cell chronic lymphocytic leukemia.